Novel Vaginal Gel Prevents Pregnancy On-Demand
By HospiMedica International staff writers Posted on 15 Sep 2020 |
Image: The Phexxi vaginal gel contraceptive system (Photo courtesy of Evofem Biosciences)
A new non-hormonal gel prevents contraception by keeping vaginal pH levels in a range that is inhospitable to sperm.
The new contraceptive, named Phexxi, a product of Evofem Biosciences (San Diego, CA, USA), developed at the University of Illinois in Chicago (UIC, USA), is based on a combination of lactic acid (1.8%), citric acid (1%), and potassium bitartrate (0.4%). Provided in a pre-filled, ready to use applicator, it works by maintaining the vagina's natural acidic pH level, killing male sperm. To maintain long-term efficacy, Phexxi creates a bioadhesive, viscous layer of gel that coats the vaginal and cervical surfaces, which allows it to remain in place and maintain the acidic environment.
To use Phexxi, the pre-filled applicator and plunger rod are removed from the foil pouch. The plunger rod is inserted into the applicator, and pushed until the two connect. The pink protective cap is then removed. In an appropriate position, the pre-filled applicator is inserted into the vagina as far as it will comfortably go, at which point the plunger rod is pushed until it stops; the single-use delivery device is then disposed of. The gel is effective immediately, delivering a dose of contraceptive gel that lasts up to one hour, which is only effective when used before sex.
“There are any women who feel that hormonal, long-acting birth control is not a viable option, and there are women who struggle to access prescription or implanted birth control due to lack of insurance or access to health care,” said UIC professor of pharmacology Donald Waller, PhD, who developed Phexxi in collaboration with Lourens Zaneveld, PhD, of Rush University Medical Center (Chicago, IL, USA). “There is a need for in-the-moment options that give women control, and I think many women will appreciate that such an option does not rely on steroid hormones. My hope is that women feel empowered with options to protect themselves.”
Vaginal pH levels are crucial to maintaining a healthy environment and preventing bacteria growth. Vaginal pH balance is maintained at a homeostasis between 4 and 4.5 due to Lactobacilli, naturally occurring bacteria that produce lactic acid, which helps reduce the reproduction of alkaline bacteria that can cause bacterial and yeast infections. During intercourse, vaginal pH levels may rise to protect the sperm as it travels towards the egg.
Related Links:
Evofem Biosciences
University of Illinois in Chicago
The new contraceptive, named Phexxi, a product of Evofem Biosciences (San Diego, CA, USA), developed at the University of Illinois in Chicago (UIC, USA), is based on a combination of lactic acid (1.8%), citric acid (1%), and potassium bitartrate (0.4%). Provided in a pre-filled, ready to use applicator, it works by maintaining the vagina's natural acidic pH level, killing male sperm. To maintain long-term efficacy, Phexxi creates a bioadhesive, viscous layer of gel that coats the vaginal and cervical surfaces, which allows it to remain in place and maintain the acidic environment.
To use Phexxi, the pre-filled applicator and plunger rod are removed from the foil pouch. The plunger rod is inserted into the applicator, and pushed until the two connect. The pink protective cap is then removed. In an appropriate position, the pre-filled applicator is inserted into the vagina as far as it will comfortably go, at which point the plunger rod is pushed until it stops; the single-use delivery device is then disposed of. The gel is effective immediately, delivering a dose of contraceptive gel that lasts up to one hour, which is only effective when used before sex.
“There are any women who feel that hormonal, long-acting birth control is not a viable option, and there are women who struggle to access prescription or implanted birth control due to lack of insurance or access to health care,” said UIC professor of pharmacology Donald Waller, PhD, who developed Phexxi in collaboration with Lourens Zaneveld, PhD, of Rush University Medical Center (Chicago, IL, USA). “There is a need for in-the-moment options that give women control, and I think many women will appreciate that such an option does not rely on steroid hormones. My hope is that women feel empowered with options to protect themselves.”
Vaginal pH levels are crucial to maintaining a healthy environment and preventing bacteria growth. Vaginal pH balance is maintained at a homeostasis between 4 and 4.5 due to Lactobacilli, naturally occurring bacteria that produce lactic acid, which helps reduce the reproduction of alkaline bacteria that can cause bacterial and yeast infections. During intercourse, vaginal pH levels may rise to protect the sperm as it travels towards the egg.
Related Links:
Evofem Biosciences
University of Illinois in Chicago
Latest Patient Care News
- Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization
- Game-Changing Innovation in Surgical Instrument Sterilization Significantly Improves OR Throughput
- Next Gen ICU Bed to Help Address Complex Critical Care Needs
- Groundbreaking AI-Powered UV-C Disinfection Technology Redefines Infection Control Landscape
- Clean Hospitals Can Reduce Antibiotic Resistance, Save Lives
- Smart Hospital Beds Improve Accuracy of Medical Diagnosis
- New Fast Endoscope Drying System Improves Productivity and Traceability
- World’s First Automated Endoscope Cleaner Fights Antimicrobial Resistance
- Portable High-Capacity Digital Stretcher Scales Provide Precision Weighing for Patients in ER
- Portable Clinical Scale with Remote Indicator Allows for Flexible Patient Weighing Use
- Innovative and Highly Customizable Medical Carts Offer Unlimited Configuration Possibilities
- Biomolecular Wound Healing Film Adheres to Sensitive Tissue and Releases Active Ingredients
- Wearable Health Tech Could Measure Gases Released From Skin to Monitor Metabolic Diseases
- Wearable Cardioverter Defibrillator System Protects Patients at Risk of Sudden Cardiac Arrest
- World's First AI-Ready Infrasound Stethoscope Listens to Bodily Sounds Not Audible to Human Ear
- POC Diagnostic Platform Offers Handheld, Instrument-Free PCR Testing for STIs